| A novel integrated cytogenetic and genomic classification refines risk stratification in pediatric acute lymphoblastic leukemia AV Moorman, A Enshaei, C Schwab, R Wade, L Chilton, A Elliott, ... Blood, The Journal of the American Society of Hematology 124 (9), 1434-1444, 2014 | 243 | 2014 |
| Genotype-specific minimal residual disease interpretation improves stratification in pediatric acute lymphoblastic leukemia D O’Connor, A Enshaei, J Bartram, J Hancock, CJ Harrison, R Hough, ... Journal of Clinical Oncology 36 (1), 34-43, 2018 | 163 | 2018 |
| Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia JAE Irving, A Enshaei, CA Parker, R Sutton, RP Kuiper, A Erhorn, L Minto, ... Blood, The Journal of the American Society of Hematology 128 (7), 911-922, 2016 | 136 | 2016 |
| Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative study JM Boer, A van der Veer, D Rizopoulos, M Fiocco, E Sonneveld, ... Leukemia 30 (1), 32-38, 2016 | 113 | 2016 |
| IGH@ Translocations Are Prevalent in Teenagers and Young Adults With Acute Lymphoblastic Leukemia and Are Associated With a Poor Outcome LJ Russell, A Enshaei, L Jones, A Erhorn, D Masic, H Bentley, KS Laczko, ... Journal of clinical oncology 32 (14), 1453-1462, 2014 | 105 | 2014 |
| Artificial intelligence systems as prognostic and predictive tools in ovarian cancer A Enshaei, CN Robson, RJ Edmondson Annals of surgical oncology 22, 3970-3975, 2015 | 102 | 2015 |
| The clinical characteristics, therapy and outcome of 85 adults with acute lymphoblastic leukemia and t (4; 11)(q21; q23)/MLL-AFF1 prospectively treated in the UKALLXII/ECOG2993 … DI Marks, AV Moorman, L Chilton, E Paietta, A Enshaie, G DeWald, ... haematologica 98 (6), 945, 2013 | 80 | 2013 |
| Validation of the United Kingdom copy-number alteration classifier in 3239 children with B-cell precursor ALL L Hamadeh, A Enshaei, C Schwab, CN Alonso, A Attarbaschi, G Barbany, ... Blood advances 3 (2), 148-157, 2019 | 68 | 2019 |
| Characterisation of the genomic landscape of CRLF2‐rearranged acute lymphoblastic leukemia LJ Russell, L Jones, A Enshaei, S Tonin, SL Ryan, J Eswaran, S Nakjang, ... Genes, Chromosomes and Cancer 56 (5), 363-372, 2017 | 61 | 2017 |
| Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study Moorman AV, Barretta E, Butler ER, Ward EJ, Twentyman K, Kirkwood AA ... Leukemia 36, 625-636, 2022 | 50 | 2022 |
| Epigenetic landscape correlates with genetic subtype but does not predict outcome in childhood acute lymphoblastic leukemia AS Gabriel, FM Lafta, EC Schwalbe, S Nakjang, SJ Cockell, A Iliasova, ... Epigenetics 10 (8), 717-726, 2015 | 44 | 2015 |
| Defining low-risk high hyperdiploidy in patients with paediatric acute lymphoblastic leukaemia: a retrospective analysis of data from the UKALL97/99 and UKALL2003 clinical trials Amir Enshaei, Ajay Vora, Christine J Harrison, John Moppett, Anthony V Moorman The Lancet Haematology 8 (11), e828-e839, 2021 | 39 | 2021 |
| A validated novel continuous prognostic index to deliver stratified medicine in pediatric acute lymphoblastic leukemia A Enshaei, D O’Connor, J Bartram, J Hancock, CJ Harrison, R Hough, ... Blood, The Journal of the American Society of Hematology 135 (17), 1438-1446, 2020 | 36 | 2020 |
| Phase II-like murine trial identifies synergy between dexamethasone and dasatinib in T-cell acute lymphoblastic leukemia Y Shi, MC Beckett, HJ Blair, R Tirtakusuma, S Nakjang, A Enshaei, ... Haematologica 106 (4), 1056, 2021 | 35 | 2021 |
| Minimal methylation classifier (MIMIC): A novel method for derivation and rapid diagnostic detection of disease-associated DNA methylation signatures EC Schwalbe, D Hicks, G Rafiee, M Bashton, H Gohlke, A Enshaei, ... Scientific reports 7 (1), 13421, 2017 | 34 | 2017 |
| Long-term follow-up of ETV6–RUNX1 ALL reveals that NCI risk, rather than secondary genetic abnormalities, is the key risk factor A Enshaei, CJ Schwab, ZJ Konn, CD Mitchell, SE Kinsey, R Wade, A Vora, ... Leukemia 27 (11), 2256-2259, 2013 | 33 | 2013 |
| Genomic abnormalities of TP53 define distinct risk groups of paediatric B-cell non-Hodgkin lymphoma AM Newman, M Zaka, P Zhou, AE Blain, A Erhorn, A Barnard, ... Leukemia 36 (3), 781-789, 2022 | 26 | 2022 |
| Integrative genomic analysis of childhood acute lymphoblastic leukaemia lacking a genetic biomarker in the UKALL2003 clinical trial C Schwab, RE Cranston, SL Ryan, E Butler, E Winterman, Z Hawking, ... Leukemia 37 (3), 529-538, 2023 | 17 | 2023 |
| Minimal residual disease, long-term outcome, and IKZF1 deletions in children and adolescents with Down syndrome and acute lymphocytic leukaemia: a matched cohort study N Michels, JM Boer, A Enshaei, R Sutton, M Heyman, S Ebert, M Fiocco, ... The Lancet Haematology 8 (10), e700-e710, 2021 | 15 | 2021 |
| Time to cure for childhood and young adult acute lymphoblastic leukemia is independent of early risk factors: long-term follow-up of the UKALL2003 trial AV Moorman, G Antony, R Wade, ER Butler, A Enshaei, CJ Harrison, ... Journal of Clinical Oncology 40 (36), 4228-4239, 2022 | 14 | 2022 |
Anthony MoormanProfessor of Genetic Epidemiology, Newcastle University在 newcastle.ac.uk 的电子邮件经过验证
